Normothermic blood polarizing versus depolarizing cardioplegia in a porcine model of cardiopulmonary bypass

Interact Cardiovasc Thorac Surg. 2022 Jun 15;35(1):ivac152. doi: 10.1093/icvts/ivac152.

Abstract

Objectives: We have previously demonstrated beneficial cardiac protection with hypothermic polarizing cardioplegia compared to a hyperkalemic depolarizing cardioplegia. In this study, a porcine model of cardiopulmonary bypass was used to compare the protective effects of normothermic blood-based polarizing and depolarizing cardioplegia during cardiac arrest.

Methods: Thirteen pigs were randomized to receive either normothermic polarizing (n = 8) or depolarizing (n = 5) blood-based cardioplegia. After initiation of cardiopulmonary bypass, normothermic arrest (34°C, 60 min) was followed by 60 min of on-pump and 90 min of off-pump reperfusion. Primary outcome was myocardial injury measured as arterial myocardial creatine kinase concentration. Secondary outcome was haemodynamic function and the energy state of the hearts.

Results: During reperfusion, release of myocardial creatine kinase was comparable between groups (P = 0.36). In addition, most haemodynamic parameters showed comparable results between groups, but stroke volume (P = 0.03) was significantly lower in the polarizing group. Adenosine triphosphate levels were significantly (18.41 ± 3.86 vs 22.97 ± 2.73 nmol/mg; P = 0.03) lower in polarizing hearts, and the requirement for noradrenaline administration (P = 0.002) and temporary pacing (6 vs 0; P = 0.02) during reperfusion were significantly higher in polarizing hearts.

Conclusions: Under normothermic conditions, polarizing blood cardioplegia was associated with similar myocardial injury to depolarizing blood cardioplegia. Reduced haemodynamic and metabolic outcome and a higher need for temporary pacing with polarized arrest may be associated with the blood-based dilution of this solution.

Keywords: Cardioplegia; Cardioprotection; Depolarized arrest; Ischaemia–reperfusion; Normothermia; Polarized arrest.

MeSH terms

  • Animals
  • Cardioplegic Solutions / pharmacology
  • Cardiopulmonary Bypass* / adverse effects
  • Cardiopulmonary Bypass* / methods
  • Creatine Kinase, MB Form
  • Heart
  • Heart Arrest*
  • Heart Arrest, Induced / adverse effects
  • Heart Arrest, Induced / methods
  • Myocardium / metabolism
  • Swine

Substances

  • Cardioplegic Solutions
  • Creatine Kinase, MB Form

Grants and funding